Answers are grounded in this paper and cite their sources.
A Schiff base ligand derived from condensation of S-benzyldithiocarbazate (SBDTC) and salicylaldehyde, and its U(VI), Th(IV) and Zr(IV) complexes have been synthesized. The compounds are characterized by elemental analysis, molar conductance, magnetic moments, UV-Vis, FT-IR and 1H NMR spectra. The Schiff base ligand coordinates via azomethine nitrogen, thiol sulfur and/or the phenolic OH group, and acts as bidentate in case of U(VI) and Zr(IV) ions and tridentate with Th(IV) ion. The U(VI) and Th(IV) complexes are 1 : 2 electrolytes whereas Zr(IV) complex is non-electrolytic. All the compounds have been tested for their antibacterial activity against four pathogenic bacteria, two Gram-negative Escherichia coli and Shigella dysenteriae and two Gram-positive Staphylococcus aureus and Bacillus subtilis using Kanamycin (K-30) as a standard. The U(VI) and Th(IV) complexes exhibit stronger antibacterial activity than the Zr(IV) complex against all tested organisms.
No takes yet. Share an insight, caveat, or question.
Bitu et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: